Administrative Core
行政核心
基本信息
- 批准号:10267705
- 负责人:
- 金额:$ 59.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-24 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AdherenceAdvanced Malignant NeoplasmAdvisory CommitteesAwardBudgetsChicagoClinicalCollaborationsCommunicationCommunitiesComprehensive Cancer CenterCoordination and CollaborationDecision MakingEducation and OutreachEnsureEvaluationFacultyFoundationsGoalsGuidelinesIllinoisIndividualInfrastructureInstitutionInstitutional PolicyLeadLeadershipLogicMalignant NeoplasmsManualsMentorsMinorityMinority-Serving InstitutionModelingProcessProtocols documentationReportingResearchResourcesSolidStreamStructureStudent recruitmentStudentsTalentsTimeUniversitiesWorkanticancer researchcancer health disparitycareercareer developmentconflict resolutionearly-career facultyexperiencehealth equityimprovedinterestmeetingsmemberoperationprogramsrecruitresearch facilitytool
项目摘要
ADMINISTRATIVE CORE – ABSTRACT
The Chicago Cancer Health Equity Collaborative (ChicagoCHEC) Administrative Core (AC) leverages a shared
governance model in order to fulfill its responsibilities to establish mechanisms and infrastructure that promote
planning, communication, interaction, integration, and evaluation that support the broad spectrum of research,
education, and outreach activities to advance cancer health equity. ChicagoCHEC builds on the solid foundation
of a 10-year collaborative track record that includes our first NCI U54 Comprehensive Partnership to Advance
Cancer Health Equity (CPACHE) award. The AC, led by a tri-institutional MPI team, capitalizes on the strengths
of each institution and leverages those strengths to build cancer research capacity at two minority serving
institutions University of Illinois at Chicago (UIC) and Northeastern Illinois University (NEIU), and to expand
cancer disparities research at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University
(NU-LCC). AC leadership is instrumental in guiding our Partnership, identifying resources, building collaborative
ties, capacity building, and helping facilitate faculty and students advancement in cancer research, education,
and outreach within the framework of institutional policies. The AC team from UIC, NEIU and NU-LCC have
worked together in varying capacities for the past 10 years and are a well-integrated team, laying the groundwork
for a strong collaboration upon which to launch and sustain ChicagoCHEC’s next chapter. To guide operations
and ensure best practices and the realization of targeted milestones in all Partnership activities, we will leverage
our established standard operating protocol, a full operations manual, and detailed logic models that guide
Partnership activities and evaluation processes. Our AC is guided by an Internal Advisory Committee (IAC) and
a Program Steering Committee (PSC). We now plan to further advance the foundation built through our initial
U54 award to fulfill the following Specific Aims: (1) Provide overall support for ChicagoCHEC activities, ensuring
integration, coordination, collaboration, and fiscal administration across the Projects and Cores; (2) Refine and
maintain communication processes and structures to enhance the overall visibility of the ChicagoCHEC
Partnership; (3) Facilitate mechanisms to optimize integration with, and efficient utilization of, institutional
resources within the partnering institutions NU-LCC, UIC, and NEIU; (4) Organize and maintain a robust pipeline
for continuous recruitment of students and faculty from minority and underrepresented backgrounds into this
Partnership; and (5) Drive iterative and robust evaluation of all ChicagoCHEC Partnership activities.
行政核心 - 摘要
芝加哥癌症卫生公平协作(芝加哥)行政核心(AC)利用共享
治理模型是为了履行其建立促进机制和基础设施的责任
计划,沟通,互动,集成和评估,以支持广泛的研究,
教育和推进活动以促进癌症健康公平。芝加哥在坚实的基础上建立
一项为期10年的合作记录,其中包括我们的第一个NCI U54综合合作伙伴关系
癌症健康平等(CPACHE)奖。由三机构MPI团队领导的AC利用了优势
每个机构都利用这些优势在两个少数派服务中建立癌症研究能力
伊利诺伊大学芝加哥大学(UIC)和伊利诺伊州东北大学(NEIU)的机构,并扩大
西北大学罗伯特·H·卢里综合癌症中心的癌症差异研究
(NU-LCC)。 AC领导力有助于指导我们的合作伙伴关系,确定资源,建立协作
联系,能力建设并帮助促进教师和学生在癌症研究,教育,教育方面的进步,
并在机构政策的框架内进行宣传。 UIC,NEIU和NU-LCC的交流团队有
在过去的10年中,以不同的能力一起工作,是一支良好的团队,奠定了基础。
为了进行强有力的合作,可以推出和维持芝加哥的下一章。指导操作
并确保最佳实践和实现目标里程碑在所有伙伴关系活动中,我们将利用
我们已建立的标准操作协议,完整的操作手册以及指导的详细逻辑模型
伙伴关系活动和评估过程。我们的AC由内部咨询委员会(IAC)和
计划指导委员会(PSC)。现在,我们计划进一步推进通过我们的初始建立的基础
U54奖旨在实现以下特定目标:(1)为芝加哥活动提供总体支持,以确保
整个项目和核心的集成,协调,协作和财政管理; (2)精炼和
保持沟通过程和结构以提高芝加哥的整体可见性
合伙; (3)促进机制优化机构的整合并有效利用
合作机构中的资源NU-LCC,UIC和NEIU; (4)组织和维持强大的管道
为了持续招募来自少数群体和代表性不足背景的学生和教职员工
合伙; (5)推动对所有芝加哥伙伴关系活动的迭代和强大评估。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marian L. Fitzgibbon其他文献
Motor Slowing in Asymptomatic HIV Infection
无症状艾滋病毒感染者运动减慢
- DOI:
10.2466/pms.1989.68.3c.1331 - 发表时间:
1989 - 期刊:
- 影响因子:1.6
- 作者:
Marian L. Fitzgibbon;D. Cella;G. Humfleet;Eugene Griffin;K. Sheridan - 通讯作者:
K. Sheridan
Heterogeneity of clinical presentation among obese individuals seeking treatment.
寻求治疗的肥胖个体临床表现的异质性。
- DOI:
10.1016/0306-4603(90)90072-6 - 发表时间:
1990 - 期刊:
- 影响因子:4.4
- 作者:
Marian L. Fitzgibbon;Daniel S. Kirschenbaum - 通讯作者:
Daniel S. Kirschenbaum
Marian L. Fitzgibbon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marian L. Fitzgibbon', 18)}}的其他基金
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer Risk
地中海饮食和减肥:针对胆汁酸/肠道微生物轴来降低结直肠癌风险
- 批准号:
10543452 - 财政年份:2021
- 资助金额:
$ 59.91万 - 项目类别:
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer Risk
地中海饮食和减肥:针对胆汁酸/肠道微生物轴来降低结直肠癌风险
- 批准号:
10328968 - 财政年份:2021
- 资助金额:
$ 59.91万 - 项目类别:
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer Risk
地中海饮食和减肥:针对胆汁酸/肠道微生物轴来降低结直肠癌风险
- 批准号:
10117630 - 财政年份:2021
- 资助金额:
$ 59.91万 - 项目类别:
Mediterranean Diet, Weight Loss, and Cognition in Obese Older Adults
地中海饮食、减肥和肥胖老年人的认知
- 批准号:
9921480 - 财政年份:2016
- 资助金额:
$ 59.91万 - 项目类别:
Mediterranean Diet, Weight Loss, and Cognition in Obese Older Adults
地中海饮食、减肥和肥胖老年人的认知
- 批准号:
9302828 - 财政年份:2016
- 资助金额:
$ 59.91万 - 项目类别:
Society of Behavioral Medicine 2016 Annual Meeting & Scientific Sessions
行为医学学会2016年年会
- 批准号:
9121875 - 财政年份:2016
- 资助金额:
$ 59.91万 - 项目类别:
Mediterranean Diet, Weight Loss, and Cognition in Obese Older Adults
地中海饮食、减肥和肥胖老年人的认知
- 批准号:
9115315 - 财政年份:2016
- 资助金额:
$ 59.91万 - 项目类别:
Comparative Effectiveness of Customary Fit and Strong! vs. Fit and Strong! Plus
习惯贴合和强健的对比效果!
- 批准号:
8295600 - 财政年份:2012
- 资助金额:
$ 59.91万 - 项目类别:
相似海外基金
A clinical prediction rule for identifying South African colorectal cancer patients who will fail to engage in oncology care
用于识别无法参与肿瘤护理的南非结直肠癌患者的临床预测规则
- 批准号:
10480832 - 财政年份:2021
- 资助金额:
$ 59.91万 - 项目类别:
Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age
发现并验证用于检测 50 岁以下受试者结直肠癌的甲基化循环肿瘤 DNA 标记
- 批准号:
10306165 - 财政年份:2021
- 资助金额:
$ 59.91万 - 项目类别:
A clinical prediction rule for identifying South African colorectal cancer patients who will fail to engage in oncology care
用于识别无法参与肿瘤护理的南非结直肠癌患者的临床预测规则
- 批准号:
10689780 - 财政年份:2021
- 资助金额:
$ 59.91万 - 项目类别:
A clinical prediction rule for identifying South African colorectal cancer patients who will fail to engage in oncology care
用于识别无法参与肿瘤护理的南非结直肠癌患者的临床预测规则
- 批准号:
10295819 - 财政年份:2021
- 资助金额:
$ 59.91万 - 项目类别:
Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age
发现并验证用于检测 50 岁以下受试者结直肠癌的甲基化循环肿瘤 DNA 标记
- 批准号:
10436983 - 财政年份:2021
- 资助金额:
$ 59.91万 - 项目类别: